Skip to main content
BGI Genomics Co., Ltd. logo

BGI Genomics Co., Ltd. — Investor Relations & Filings

Ticker · 300676 ISIN · CNE100003449 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 1,653 across all filing types
Latest filing 2025-10-23 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 300676

About BGI Genomics Co., Ltd.

https://www.bgi.com

BGI Genomics Co., Ltd. is a leading provider of integrated solutions for precision medicine, specializing in genomic sequencing and proteomic services. The company offers a comprehensive portfolio of clinical diagnostics and research services across various fields, including reproductive health, oncology, and infectious diseases. Key products include non-invasive prenatal testing, hereditary cancer screening, and pathogen identification tools. Leveraging proprietary DNBseq sequencing technology, BGI Genomics provides high-throughput, cost-effective genomic data analysis to healthcare providers, research institutions, and pharmaceutical companies worldwide. The organization focuses on advancing personalized medicine through large-scale genomic research and the development of innovative diagnostic applications, aiming to improve health outcomes by making advanced genetic insights accessible to a global population.

Recent filings

Filing Released Lang Actions
2025年三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "深圳华大基因股份有限公司 2025 年第三季度报告" which translates to "Shenzhen BGI Genomics Co., Ltd. 2025 Third Quarter Report." It contains detailed financial data including balance sheets, profit and loss statements, shareholder information, and management commentary for the third quarter of 2025. The document includes comprehensive financial statements and analysis for a period shorter than a full fiscal year, specifically a quarterly report. It is not an announcement or a brief summary but a full report with substantive financial data and explanations. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2025-10-23 Chinese
董事会议事规则（2025年10月）
Governance Information Classification · 100% confidence The document is titled '董事会议事规则' which translates to 'Rules of Procedure for the Board of Directors'. It details the internal rules, procedures, and governance practices for the board meetings of Shenzhen BGI Genomics Co., Ltd. It covers topics such as meeting convocations, voting procedures, responsibilities, and record-keeping. There is no financial data, earnings information, or regulatory filings related to financial results. The content is focused on governance structure and board operations, which aligns with the definition of Governance Information (CGR). The document length is sufficient and it is not an announcement or a brief notice but a full set of governance rules. Therefore, the appropriate classification is CGR with high confidence.
2025-10-23 Chinese
总经理工作细则（2025年10月）
Governance Information Classification · 95% confidence The document is titled '总经理工作细则' (General Manager Work Rules) and details the governance structure, roles, responsibilities, appointment, and reporting procedures of the company's general manager and senior management. It references company bylaws, legal regulations, and internal governance practices. There is no financial data, earnings information, or audit content. It is a governance-related internal policy document rather than a financial report or announcement. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-10-23 Chinese
信息披露管理制度（2025年10月）
Governance Information Classification · 95% confidence The document is titled '信息披露管理制度' which translates to 'Information Disclosure Management System' and is issued by Shenzhen BGI Genomics Co., Ltd. It extensively details the company's policies, procedures, responsibilities, and legal compliance related to information disclosure. It covers definitions, principles, types of reports (annual, interim, quarterly, and temporary), disclosure timing, responsibilities of directors and management, confidentiality measures, archival management, and accountability mechanisms. The document is a comprehensive internal governance and compliance manual for information disclosure rather than an actual financial report or announcement. It does not contain financial statements, earnings data, or audit results. It is not a report publication announcement or a regulatory filing of a specific event but a governance document outlining disclosure rules and procedures. Therefore, the most appropriate classification is Governance Information (CGR). The document length (over 13,000 characters) and detailed content support this classification with high confidence.
2025-10-23 Chinese
重大信息内部报告制度（2025年10月）
Governance Information Classification · 95% confidence The document is titled '重大信息内部报告制度' which translates to 'Major Information Internal Reporting System' and is issued by Shenzhen BGI Genomics Co., Ltd. It outlines internal procedures and responsibilities for reporting major information within the company, including definitions, scope, management, and confidentiality obligations. The content is regulatory and procedural in nature, focusing on internal governance and compliance with laws and stock exchange rules. It does not contain financial statements, earnings data, voting results, or announcements of specific events like mergers or dividends. It is a governance-related document detailing internal rules and processes for information disclosure and management. Therefore, it fits best under Governance Information (CGR). The document length (6077 characters) and detailed procedural content support this classification with high confidence.
2025-10-23 Chinese
内幕信息知情人登记管理制度（2025年10月）
Governance Information Classification · 95% confidence The document is titled '内幕信息知情人登记管理制度' which translates to 'Insider Information Insider Registration Management System'. It is a detailed internal policy document from Shenzhen BGI Genomics Co., Ltd. regarding the management, registration, and confidentiality of insider information and insider persons. The content includes definitions, scope, procedures for registration, confidentiality obligations, and legal responsibilities related to insider information. There is no indication that this is a financial report, earnings release, or any form of regulatory filing announcing financial results or corporate actions. It is not a report publication announcement or a certification. Instead, it is a governance-related document detailing internal rules and procedures for managing insider information within the company. Therefore, the most appropriate classification is Governance Information (CGR). The document length (6712 characters) and detailed procedural content support this classification with high confidence.
2025-10-23 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.